CBRE GROUP INC - A (CBRE) Fundamental Analysis & Valuation

NYSE:CBRE • US12504L1098

141.19 USD
-0.55 (-0.39%)
At close: Mar 5, 2026
141.19 USD
0 (0%)
After Hours: 3/5/2026, 5:28:38 PM

This CBRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall CBRE gets a fundamental rating of 5 out of 10. We evaluated CBRE against 63 industry peers in the Real Estate Management & Development industry. CBRE has an average financial health and profitability rating. CBRE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. CBRE Profitability Analysis

1.1 Basic Checks

  • CBRE had positive earnings in the past year.
  • In the past year CBRE had a positive cash flow from operations.
  • In the past 5 years CBRE has always been profitable.
  • Each year in the past 5 years CBRE had a positive operating cash flow.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • The Return On Assets of CBRE (3.75%) is better than 85.71% of its industry peers.
  • CBRE has a Return On Equity of 13.03%. This is amongst the best in the industry. CBRE outperforms 93.65% of its industry peers.
  • With a decent Return On Invested Capital value of 5.08%, CBRE is doing good in the industry, outperforming 74.60% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CBRE is in line with the industry average of 5.46%.
Industry RankSector Rank
ROA 3.75%
ROE 13.03%
ROIC 5.08%
ROA(3y)4.03%
ROA(5y)5.45%
ROE(3y)12.16%
ROE(5y)15.19%
ROIC(3y)6.32%
ROIC(5y)7.21%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • CBRE's Profit Margin of 2.85% is fine compared to the rest of the industry. CBRE outperforms 65.08% of its industry peers.
  • In the last couple of years the Profit Margin of CBRE has declined.
  • The Operating Margin of CBRE (3.19%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CBRE has declined.
  • CBRE has a Gross Margin of 18.66%. This is comparable to the rest of the industry: CBRE outperforms 42.86% of its industry peers.
  • In the last couple of years the Gross Margin of CBRE has remained more or less at the same level.
Industry RankSector Rank
OM 3.19%
PM (TTM) 2.85%
GM 18.66%
OM growth 3Y-9.5%
OM growth 5Y-5.5%
PM growth 3Y-14.49%
PM growth 5Y-2%
GM growth 3Y-3.73%
GM growth 5Y-1.09%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

4

2. CBRE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBRE is destroying value.
  • The number of shares outstanding for CBRE has been reduced compared to 1 year ago.
  • The number of shares outstanding for CBRE has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CBRE has a worse debt to assets ratio.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • CBRE has an Altman-Z score of 3.10. This indicates that CBRE is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.10, CBRE is in the better half of the industry, outperforming 69.84% of the companies in the same industry.
  • The Debt to FCF ratio of CBRE is 6.56, which is on the high side as it means it would take CBRE, 6.56 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 6.56, CBRE is doing good in the industry, outperforming 69.84% of the companies in the same industry.
  • A Debt/Equity ratio of 0.87 indicates that CBRE is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.87, CBRE is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 6.56
Altman-Z 3.1
ROIC/WACC0.61
WACC8.39%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • CBRE has a Current Ratio of 1.09. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
  • CBRE has a Current ratio of 1.09. This is in the lower half of the industry: CBRE underperforms 73.02% of its industry peers.
  • A Quick Ratio of 1.09 indicates that CBRE should not have too much problems paying its short term obligations.
  • CBRE has a Quick ratio of 1.09. This is in the lower half of the industry: CBRE underperforms 69.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

6

3. CBRE Growth Analysis

3.1 Past

  • CBRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.05%, which is quite impressive.
  • Measured over the past years, CBRE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.27% on average per year.
  • Looking at the last year, CBRE shows a quite strong growth in Revenue. The Revenue has grown by 13.38% in the last year.
  • Measured over the past years, CBRE shows a quite strong growth in Revenue. The Revenue has been growing by 11.22% on average per year.
EPS 1Y (TTM)25.05%
EPS 3Y4%
EPS 5Y14.27%
EPS Q2Q%17.67%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y9.57%
Revenue growth 5Y11.22%
Sales Q2Q%11.77%

3.2 Future

  • CBRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.27% yearly.
  • CBRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.74% yearly.
EPS Next Y17.7%
EPS Next 2Y16.88%
EPS Next 3Y17.12%
EPS Next 5Y16.27%
Revenue Next Year11.08%
Revenue Next 2Y10.02%
Revenue Next 3Y9.54%
Revenue Next 5Y7.74%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

5

4. CBRE Valuation Analysis

4.1 Price/Earnings Ratio

  • CBRE is valuated rather expensively with a Price/Earnings ratio of 22.10.
  • Based on the Price/Earnings ratio, CBRE is valued a bit cheaper than the industry average as 76.19% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.74, CBRE is valued at the same level.
  • CBRE is valuated rather expensively with a Price/Forward Earnings ratio of 18.77.
  • CBRE's Price/Forward Earnings ratio is rather cheap when compared to the industry. CBRE is cheaper than 85.71% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.82, CBRE is valued a bit cheaper.
Industry RankSector Rank
PE 22.1
Fwd PE 18.77
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 69.84% of the companies listed in the same industry.
  • 68.25% of the companies in the same industry are more expensive than CBRE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 35.22
EV/EBITDA 20.56
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • CBRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of CBRE may justify a higher PE ratio.
  • A more expensive valuation may be justified as CBRE's earnings are expected to grow with 17.12% in the coming years.
PEG (NY)1.25
PEG (5Y)1.55
EPS Next 2Y16.88%
EPS Next 3Y17.12%

0

5. CBRE Dividend Analysis

5.1 Amount

  • No dividends for CBRE!.
Industry RankSector Rank
Dividend Yield 0%

CBRE Fundamentals: All Metrics, Ratios and Statistics

CBRE GROUP INC - A

NYSE:CBRE (3/5/2026, 5:28:38 PM)

After market: 141.19 0 (0%)

141.19

-0.55 (-0.39%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-12
Earnings (Next)04-22
Inst Owners97.94%
Inst Owner Change0.57%
Ins Owners0.51%
Ins Owner Change6.04%
Market Cap42.02B
Revenue(TTM)40.55B
Net Income(TTM)1.16B
Analysts82
Price Target189.93 (34.52%)
Short Float %1.35%
Short Ratio1.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.98%
Min EPS beat(2)0.04%
Max EPS beat(2)7.92%
EPS beat(4)4
Avg EPS beat(4)6.74%
Min EPS beat(4)0.04%
Max EPS beat(4)10.42%
EPS beat(8)8
Avg EPS beat(8)7.13%
EPS beat(12)12
Avg EPS beat(12)7.3%
EPS beat(16)15
Avg EPS beat(16)8.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-0.77%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)1.13%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)7
Avg Revenue beat(16)-0.24%
PT rev (1m)-0.62%
PT rev (3m)4.23%
EPS NQ rev (1m)6.44%
EPS NQ rev (3m)6.74%
EPS NY rev (1m)0.09%
EPS NY rev (3m)0.75%
Revenue NQ rev (1m)3.91%
Revenue NQ rev (3m)3.91%
Revenue NY rev (1m)1.35%
Revenue NY rev (3m)1.33%
Valuation
Industry RankSector Rank
PE 22.1
Fwd PE 18.77
P/S 1.04
P/FCF 35.22
P/OCF 26.95
P/B 4.73
P/tB N/A
EV/EBITDA 20.56
EPS(TTM)6.39
EY4.53%
EPS(NY)7.52
Fwd EY5.33%
FCF(TTM)4.01
FCFY2.84%
OCF(TTM)5.24
OCFY3.71%
SpS136.26
BVpS29.83
TBVpS-3.85
PEG (NY)1.25
PEG (5Y)1.55
Graham Number65.49
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 13.03%
ROCE 6.97%
ROIC 5.08%
ROICexc 5.57%
ROICexgc 11.69%
OM 3.19%
PM (TTM) 2.85%
GM 18.66%
FCFM 2.94%
ROA(3y)4.03%
ROA(5y)5.45%
ROE(3y)12.16%
ROE(5y)15.19%
ROIC(3y)6.32%
ROIC(5y)7.21%
ROICexc(3y)6.87%
ROICexc(5y)8.07%
ROICexgc(3y)14.53%
ROICexgc(5y)18.56%
ROCE(3y)8.23%
ROCE(5y)9.39%
ROICexgc growth 3Y-21.33%
ROICexgc growth 5Y-6.1%
ROICexc growth 3Y-16.05%
ROICexc growth 5Y-7%
OM growth 3Y-9.5%
OM growth 5Y-5.5%
PM growth 3Y-14.49%
PM growth 5Y-2%
GM growth 3Y-3.73%
GM growth 5Y-1.09%
F-Score5
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 6.56
Debt/EBITDA 3.46
Cap/Depr 39.44%
Cap/Sales 0.9%
Interest Coverage 2.89
Cash Conversion 70.19%
Profit Quality 103.11%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 3.1
F-Score5
WACC8.39%
ROIC/WACC0.61
Cap/Depr(3y)44.67%
Cap/Depr(5y)43.27%
Cap/Sales(3y)0.91%
Cap/Sales(5y)0.86%
Profit Quality(3y)88.53%
Profit Quality(5y)96.03%
High Growth Momentum
Growth
EPS 1Y (TTM)25.05%
EPS 3Y4%
EPS 5Y14.27%
EPS Q2Q%17.67%
EPS Next Y17.7%
EPS Next 2Y16.88%
EPS Next 3Y17.12%
EPS Next 5Y16.27%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y9.57%
Revenue growth 5Y11.22%
Sales Q2Q%11.77%
Revenue Next Year11.08%
Revenue Next 2Y10.02%
Revenue Next 3Y9.54%
Revenue Next 5Y7.74%
EBIT growth 1Y-15.16%
EBIT growth 3Y-0.84%
EBIT growth 5Y5.11%
EBIT Next Year51.22%
EBIT Next 3Y22.77%
EBIT Next 5Y14.45%
FCF growth 1Y-14.85%
FCF growth 3Y-4.48%
FCF growth 5Y-5.27%
OCF growth 1Y-8.72%
OCF growth 3Y-1.46%
OCF growth 5Y-3.16%

CBRE GROUP INC - A / CBRE FAQ

What is the fundamental rating for CBRE stock?

ChartMill assigns a fundamental rating of 5 / 10 to CBRE.


What is the valuation status of CBRE GROUP INC - A (CBRE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CBRE GROUP INC - A (CBRE). This can be considered as Fairly Valued.


What is the profitability of CBRE stock?

CBRE GROUP INC - A (CBRE) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for CBRE stock?

The Earnings per Share (EPS) of CBRE GROUP INC - A (CBRE) is expected to grow by 17.7% in the next year.